Preventing Moderate to Severe Radiation Skin Reactions in Women Receiving Adjuvant Radiotherapy for Breast Cancer Using a Skin Care Reminder App
Led by University Hospital Schleswig-Holstein · Updated on 2025-01-16
268
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether using a reminder app alongside standard skin care helps reduce the occurrence of moderate to severe radiation dermatitis in female breast cancer patients receiving adjuvant radiotherapy. This multinational, randomized trial compares standard skin care alone to standard skin care supported by an app that reminds patients to perform skin care four times daily. The study also looks at pain levels, patient satisfaction with the app, and how the app affects the use of health technology, especially in different age groups.
Participants receive radiotherapy over about three to four weeks using hypo-fractionated doses, with some patients receiving additional radiation boosts based on age and risk factors. All patients perform standard skin care, which includes applying fatty cream with urea and possibly mometasone furoate cream in the app-supported group, patients also receive reminders and guidance through the app. The app allows patients to set notification schedules, postpone care reminders, and earn points for adherence. Patients in the app group will complete a questionnaire on their satisfaction and the apps impact at the end of treatment.
During the study, radiation dermatitis is assessed weekly and at the end of radiotherapy by trained observers. Pain scores and patient satisfaction are also measured throughout the approximately four-week treatment period. Data on the apps use and support benefits are collected from the app group. The study includes 268 female patients aged 18 years and older with invasive breast cancer, who can use a smartphone and provide consent. Safety and compliance are monitored, with statistical analysis planned to compare outcomes between groups.
CONDITIONS
Brief Title
Dermatitis During Adjuvant Irradiation for BREAst Cancer:
Research Team
D
Dirk Rades, MD, FASTRO
C
Carlos A. Narvaez-Wolf, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Indication for adjuvant hypo-fractionated radiotherapy
Possession of and ability to use a smartphone
Female gender
Age 6518 years
Written informed consent
Capacity of the patient to contract
You will not qualify if you...
Pregnancy or lactation
Expected non-compliance
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for eligibility assessment
Treatment
Duration - 3 to 4 weeks
Participants receive adjuvant hypo-fractionated radiotherapy for invasive breast cancer while performing standard skin care. Participants in Arm A are supported by a Reminder App to help remind and motivate skin care, while participants in Arm B perform standard skin care alone. Radiation dermatitis and pain are regularly assessed during this period.
Weekly visits during radiotherapy (up to 4 visits including end of treatment)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Phase II Study of 18F-FES PETMRI Imaging to Guide Treatment for Luminal A and Lobular Breast Cancer
Evaluating Accuracy in Axillary Lymph Node Staging Compared to Surgery
Using 18F-FDG PETCT Scans to Improve Staging and Treatment Decisions in Women With High-Risk or Recurrent Breast Cancer
Evaluating Microfractionated C02 Laser and Topical Regenerative Therapy for Vulvo-vaginal Atrophy in Breast Cancer Survivors
Evaluation of the Syantra DX Blood Test for Early Detection of Breast Cancer in Women Undergoing Screening Mammography
Mapping Chest Wall Perforator Locations Using Anatomical Landmarks
for Partial Breast Reconstruction in Women Undergoing Elective Surgery
ATUSA 3D Automated Breast Ultrasound Imaging Registry for Suspicious Breast Lesions Evaluation with Multimodality Imaging and Biopsy Correlation
Evaluating Biennial Contrast-Enhanced Mammography Added to Annual 3D Mammography
for Breast Cancer Detection in Women with Personal History of Breast Cancer
Study of Body Awareness, Arm and Shoulder Function, and Quality of Life in Women Who Survived Breast Cancer Compared to Healthy Women
Study of Body Image and Physical Activity Changes in Women Treated for Breast Cancer Using a Questionnaire
Exercise Program to Support Resilience in Black Breast Cancer Survivors
A 12-Week Guided Resistance Training Compared to Waitlist Control
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Dermatitis during adjuvant irradiation for breast cancer (DAI-BREAC): a randomized controlled trial investigating whether grade ≥2 dermatitis during radiotherapy for breast cancer can be reduced by a mobile application that reminds patients to perform skin care.
Dirk Rades, Carlos Andres Narvaez-Wolf, Liesa Dziggel...